We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.33B
AUM Growth
+$88.6M
Cap. Flow
-$59.4M
Cap. Flow %
-1.37%
Top 10 Hldgs %
20%
Holding
687
New
63
Increased
226
Reduced
276
Closed
43

Top Buys

Rank Stock Value
1
MO icon
Altria Group
MO
+$24.1M
2
AVGO icon
Broadcom
AVGO
+$19.4M
3
AAL icon
American Airlines Group
AAL
+$17.2M
4
DIS icon
Walt Disney
DIS
+$17.1M
5
ADBE icon
Adobe
ADBE
+$16.3M

Top Sells

Rank Stock Value
1
ROST icon
Ross Stores
ROST
+$17.8M
2
BFH icon
Bread Financial
BFH
+$17.5M
3
URI icon
United Rentals
URI
+$17M
4
SPB icon
Spectrum Brands
SPB
+$16.9M
5
FFIV icon
F5
FFIV
+$15.9M

Sector Composition

Rank Sector Weight
1 Technology 17.01%
2 Healthcare 13.6%
3 Financials 13.28%
4 Industrials 10.77%
5 Consumer Discretionary 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAMR icon
476
Lamar Advertising Co
LAMR
$16.2B
$523K 0.01%
7,105
+225
+3% +$16.2K
QDEL icon
477
QuidelOrtho
QDEL
$1.09B
$521K 0.01%
+19,180
New +$475K
HON icon
478
Honeywell
HON
$77.1B
$520K 0.01%
4,318
+10
+0.2% +$1.18K
FRT icon
479
Federal Realty Investment Trust
FRT
$10.9B
$518K 0.01%
4,100
SI
480
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$518K 0.01%
7,494
IBDQ
481
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$511K 0.01%
20,443
+2,116
+12% +$52.7K
PMC
482
DELISTED
PharMerica Corporation
PMC
$503K 0.01%
19,180
-1,285
-6% -$31.6K
FDC
483
DELISTED
First Data Corporation
FDC
$495K 0.01%
27,199
-6,043
-18% -$101K
INGR icon
484
Ingredion
INGR
$6.38B
$491K 0.01%
4,118
-111,775
-96% -$13.3M
IVW icon
485
iShares S&P 500 Growth ETF
IVW
$72.5B
$482K 0.01%
14,100
IP icon
486
International Paper
IP
$22.3B
$481K 0.01%
8,976
-606
-6% -$30.6K
BOX icon
487
Box
BOX
$4.02B
$475K 0.01%
+26,030
New +$469K
LSCC icon
488
Lattice Semiconductor
LSCC
$17.6B
$464K 0.01%
69,625
-795
-1% -$5.44K
GHDX
489
DELISTED
Genomic Health, Inc.
GHDX
$464K 0.01%
14,245
-430
-3% -$13.6K
YELP icon
490
Yelp
YELP
$1.38B
$462K 0.01%
+15,380
New +$480K
ANIK icon
491
Anika Therapeutics
ANIK
$199M
$458K 0.01%
9,290
-170
-2% -$7.83K
CNI icon
492
Canadian National Railway
CNI
$78.3B
$456K 0.01%
5,620
IX icon
493
ORIX
IX
$44B
$455K 0.01%
29,200
ITW icon
494
Illinois Tool Works
ITW
$81.4B
$450K 0.01%
3,140
+100
+3% +$13.9K
RDS.A
495
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$450K 0.01%
8,458
-1,150
-12% -$61.6K
ADM icon
496
Archer Daniels Midland
ADM
$41.4B
$448K 0.01%
10,817
ATVI
497
DELISTED
Activision Blizzard
ATVI
$446K 0.01%
7,755
-446
-5% -$24.6K
DTE icon
498
DTE Energy
DTE
$31.1B
$440K 0.01%
4,883
NCLH icon
499
Norwegian Cruise Line
NCLH
$8.89B
$436K 0.01%
8,035
+3,765
+88% +$194K
PCY icon
500
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$430K 0.01%
14,690

Similar funds

Boston Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Boston Advisors held 687 positions worth $4.33B, up 2.1% from $4.24B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Advisors's Q2 2017 filing shows 63 new, 226 increased, 276 reduced and 43 closed positions. Its largest new stake was American Airlines Group: 369,750 shares worth $18.6M. The largest sale was Ross Stores, an estimated $17.8M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Boston Advisors's largest Q2 2017 buy was American Airlines Group: 369,750 shares worth $18.6M.
  • Boston Advisors added most to Altria Group in Q2 2017, an estimated $24.1M increase.
  • Boston Advisors's biggest Q2 2017 reduction was Ross Stores, cutting an estimated $17.8M.
  • Boston Advisors fully exited F5 in Q2 2017, selling an estimated $15.9M.
  • Boston Advisors's ten largest holdings make up 20% of its $4.33B portfolio in Q2 2017.
  • Boston Advisors opened 63 new positions and closed 43 in Q2 2017.
  • Boston Advisors's portfolio value rose 2.1% quarter-over-quarter to $4.33B.

Based on Boston Advisors's 13F filing for Q2 2017, filed 25 Jul 2017.